ニューヨーク・タイムズのインスタグラム(nytimes) - 5月11日 05時32分

Food and Drug Administration advisers concluded that the benefits outweighed the risks of making a hormonal contraceptive pill — sold under the brand name Opill and produced by the French company HRA Pharma — available without a prescription.

If the FDA follows the nonbinding recommendation of its advisers — and there is a chance the agency might not — Opill would become the first and only birth control pill to be available over the counter since oral contraceptives were introduced in the U.S. in 1960. A final decision is expected by early August.

Read more about the recommendation and what it could mean for you, at the link in bio.

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する

• ニューヨーク・タイムズ